

ALGN's Q3 earnings may benefit from Clear Aligner growth and digital innovations, while capital equipment market challenges could weigh on results.

Align Technology (ALGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

IFP Advisors Inc raised its holdings in Align Technology, Inc. (NASDAQ: ALGN) by 8,055.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 57,085 shares of the medical equipment provider's stock after acquiring an additional 56,385 shares during

Align Technology, Inc. (âAlignâ) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign System of cl

SAN JOSE, Calif. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, welcomes the decision of the Unified Patent Court (“UPC”) finding that aligner systems incorporating Angelalign's Torque Ridges feature infringe Align's European Patent EP 2 237 738 B1, which relates to Align's Power Ridge® technology.In August 2025, Align initiated patent infring.

Hotter-than-expected inflation sent stocks and crypto tumbling Wednesday, and Wall Street analysts wasted no time reshuffling their targets on Thursday, with major calls hitting Bank of America, Netflix, PayPal, and several energy giants all at once.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
